Citron Research’s tweet suggesting President-elect Donald Trump begin his war on drug pricing with pharmacy benefit manager Express Scripts caused the company’s stock to fall as much as 9 percent ...

) from Hold to Sell, while reducing the price target from $93 to $61. Hill believes that there could be downside risk of 11 percent to the stock, from the current levels. "Given the acrimony between ...